Clinical Trial: A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231991) titled 'A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function' on Nov. 13.

Brief Summary: The purpose of the study is to look at how the body processes a study medicine called vepdegestrant in participants with loss of liver function relative to people with normal liver function.

This study is seeking participants who are:

* females who cannot have children or males

* between 18 and 70 years of age

* weigh more than 50 Kilograms (110 pounds)

* either healthy with normal liver function or have loss of liver function

All participants in this study will take one dose of vepd...